Skip to content

Clinical trials

Phase 2 Lymphoma, Follicular trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Phase: Phase 2 Country / region: South Korea Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20121
20131
20142
20151
20172
20182
20193
20201
20212
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Active, not recruiting3
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals3
AMIpharm Co., Ltd.2
AstraZeneca2
Novartis Pharmaceuticals2
Samsung Medical Center2
BeiGene1
Boryung Pharmaceutical Co., Ltd1
Celgene1
Janssen Research & Development, LLC1
Korea Cancer Center Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular21
Lymphoma, Mantle-Cell7
Lymphoma, Non-Hodgkin4
Lymphoma, B-Cell3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Large B-Cell, Diffuse3
Recurrence3
Dermatitis, Atopic2
Lymphoma2
Anemia, Aplastic1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.